EAT is up +49.38%% since April’24 pick View All Top Buy Picks
RSI low/high Values: [ 15 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ZLDAF
Powered by GPT-4o
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

FAQ

What is the symbol for Zelira Therapeutics Limited Stock and on which exchange is it traded?
The symbol for Zelira Therapeutics Limited is ZLDAF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Zelira Therapeutics Limited Stock?
Zelira Therapeutics Limited holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Zelira Therapeutics Limited Stock?
Zelira Therapeutics Limited Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Zelira Therapeutics Limited Stock.

What's the current price of Zelira Therapeutics Limited Stock?
As of the end of day on the Jun 28, 2024, the price of an Zelira Therapeutics Limited (ZLDAF) share was $0.191.

What is the 52-week high and low for Zelira Therapeutics Limited Stock?
The 52-week high for Zelira Therapeutics Limited Stock is $1.29 and the 52-week low is $0.191.

What is the market capitalization of Zelira Therapeutics Limited Stock?
As of the Jun 28, 2024, the market capitalization of Zelira Therapeutics Limited is 2.17M.

When is the next earnings date for Zelira Therapeutics Limited?
The upcoming earnings date for Zelira Therapeutics Limited is Aug 27, 2024.
Click to get the best stock tips daily for free!

About Zelira Therapeutics Limited

Zelira Therapeutics Limited Zelira Therapeutics Limited, a bio-pharmaceutical company, engages in the development of cannabinoid-based medicines for the treatment of various medical conditions in Australia. The company is also involved in a human clinical trial program focused on insomnia, autism, and opioid reduction; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer, as well as the potential for cannabinoid f... ZLDAF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT